Nashville Biosciences
-
Nashville Biosciences and Illumina announce sequencing agreement with Amgen
Nashville Biosciences LLC and Illumina Inc. today announced an agreement with Amgen to whole-genome sequence approximately 35,000 DNA samples. Read MoreJan 10, 2023